Trials / Completed
CompletedNCT05051527
Study to Evaluate the Effectiveness of Legalon®
Observational, Single Arm, Prospective Study to Evaluate the Effectiveness of Legalon® in Addition to Diet and Exercise in Reducing Plasma Levels of Liver Enzymes
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 362 (actual)
- Sponsor
- Mylan Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a multinational, multicentre, prospective, non-interventional study (NIS) in non-alcoholic fatty liver disease (NAFLD) patients with concomitant metabolic syndrome treated with Legalon® combined with diet and exercise.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Legalon® 140 mg | Legalon® 140 mg as per the Summary of Product Characteristics (SPC) and as per treating Investigator's decision |
Timeline
- Start date
- 2022-08-08
- Primary completion
- 2024-10-31
- Completion
- 2024-10-31
- First posted
- 2021-09-21
- Last updated
- 2025-09-30
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT05051527. Inclusion in this directory is not an endorsement.